Ticker Details
Candel Therapeutics, Inc. Common Stock
IPO Date:	July 27, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$325M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 4.84%
Avg Daily Range (30 D):	$0.20 | 3.47%
Avg Daily Range (90 D):	$0.18 | 3.22%

Institutional Daily Volume
Avg Daily Volume:	.7M
Avg Daily Volume (30 D):	.81M
Avg Daily Volume (90 D):	.74M

Trade Size
Avg Trade Size (Sh.):	146
Avg Trade Size (Sh.) (30 D):	105
Avg Trade Size (Sh.) (90 D):	113

Institutional Trades
Total Institutional Trades:	109
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$2.96M
Avg Institutional Trade (90 D):	$1.53M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.14M
Avg Closing Trade (30 D):	$2.96M
Avg Closing Trade (90 D):	$2M
Avg Closing Volume:	316.93K

News

Nov 4, 2025 @ 2:00 PM Candel Therapeutics Showcases Immunotherapy Leader... Source: Candel Therapeutics

Apr 1, 2025 @ 12:01 PM Candel Therapeutics Announces Publication of Phase... Source: N/A

Mar 18, 2025 @ 12:00 PM Candel Therapeutics Appoints Renowned Pancreatic C... Source: N/A

Dec 12, 2024 @ 9:51 PM Candel Therapeutics Announces $80 Million Proposed... Source: N/A

Sep 4, 2024 @ 12:00 PM Milestone Pharmaceuticals Appoints Industry Vetera... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.21	$-.09
Diluted EPS		$-.21	$-.09
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-11.27M	$-4.8M
Operating Income / Loss		$-13.21M	$-11.18M
Cost of Revenue
Net Cash Flow		$-13.72M	$8.52M
PE Ratio